Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers

International Journal of Cancer

Volumn 96, Issue SUPPL., 2001, Pages 61-70

  Mittal, Bharat B ^a,e   Kepka, Alan ^a   Mahadevan, Arul ^a   Kies, Merrill ^b   Pelzer, Harold ^a   List, Marcy A ^c   Rademaker, Alfred ^a   Logemann, Jeri ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c University of Chicago   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Galter Pavilion   (United States)

Author keywords

Head and neck cancer; Intensity modulation; Tissue compensator; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SCORING SYSTEM; TISSUE DOSE COMPENSATION; XEROSTOMIA;

ADULT; AGED; DRUG THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; SALIVA; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035738577     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10360     Document Type: Article

References (37)

1. A Radiation Therapy Oncology Group (RTOG) Phase III Randomized Study to compare hyperfractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: First report of RTOG 9003
2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
3. Significant advantage of chemo-radiotherapy compared to radiation alone in randomized phase III trial for patients with esophageal cancer: An intergroup study
4. Randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III nonsmall-cell lung cancer
5. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable nonsmall-cell lung cancer: First analysis of a randomized trial in 353 patients
6. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival
7. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
8. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
9. LENT SOMA scales for all anatomic sites
10. Speech and swallowing function after anterior tongue and floor of mouth resection with distal flap reconstruction
11. Oropharyngeal swallow efficiency as a representative measure of swallowing function
12. A quantitative test for xerostomia. The saxon test
13. The functional assessment of cancer therapy scale: Development and validation of the general measure
14. A performance status scale for head and neck cancer patients
15. The performance status scale for head and neck cancer (PSS-HN) and the functional assessment of cancer therapy - Head and neck (FACT-H&N) scale: A study of utility and validity
16. The head and neck cancer radiotherapy questionnaire: A morbidity/quality of life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer
17. Performance and quality of life outcome in patients completing concomitant chemoradiotherapy for head and neck cancer
18. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination
19. Optimization of uncomplicated control for head and neck tumors
20. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity
21. Improving dose homogeneity in routine head and neck radiotherapy with custom 3-D compensation
22. Clinical considerations in the use of missing tissue compensators for head and neck cases
23. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control
24. 3D treatment planning and intensity-modulated radiation therapy
25. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx
26. Conformal radiotherapy in head and neck cancer: The Washington University experience
27. Comprehensive irradiation of head and neck cancer using conformal multisegmented fields: Assessment of target coverage and non involved tissue sparing
28. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer
29. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity modulated radiotherapy for head and neck cancer
30. Intensity modulated radiation therapy for head and neck cancers: The Mallinckrodt experience
31. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy
32. Swallowing and tongue function following treatment for oral and oropharyngeal cancer